| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/28/2011 | CA2778158A1 Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions |
| 04/28/2011 | CA2778084A1 Modified variable domain molecules and methods for producing and using same |
| 04/28/2011 | CA2777883A1 Medical utility of glycan-binding proteins and glycans |
| 04/28/2011 | CA2776576A1 Non-cross-reactive anti-igg antibodies |
| 04/28/2011 | CA2776405A1 Surface-assisted hemagglutination and hemagglutination inhibition assays |
| 04/28/2011 | CA2775924A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | CA2775595A1 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography |
| 04/28/2011 | CA2774032A1 Anti-gcc antibody molecules and related compositions and methods |
| 04/28/2011 | CA2771817A1 Modulators of hepatocyte growth factor activator |
| 04/27/2011 | EP2315026A2 Taxol immunoassay |
| 04/27/2011 | EP2314716A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 04/27/2011 | EP2314711A1 Methods for expression and purification of immunotoxins |
| 04/27/2011 | EP2314697A1 Streptococcus pneumoniae proteins and nucleic acids |
| 04/27/2011 | EP2314696A1 Therapeutic uses of human Interleukin-B50 antagonist. |
| 04/27/2011 | EP2314695A2 Ligand for receptor activator of NF-kappa B, ligand is member of TNF superfamily |
| 04/27/2011 | EP2314694A2 BAFF receptor (BCMA), an immunoregulatory agent |
| 04/27/2011 | EP2314686A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314685A1 Cells producing antibody compositions |
| 04/27/2011 | EP2314676A1 Compositions and methods for the treatment of immune related diseases |
| 04/27/2011 | EP2314629A1 Recombinant production of mixtures of antibodies |
| 04/27/2011 | EP2314628A1 Anti-cd27 antibody |
| 04/27/2011 | EP2314627A2 Method for the treatment of multiple sclerosis |
| 04/27/2011 | EP2314626A1 Antibody molecules having specificity for human IL-6 |
| 04/27/2011 | EP2314625A1 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/27/2011 | EP2314624A2 Human antibody molecules for IL-13 |
| 04/27/2011 | EP2314623A1 IL-1beta binding antibodies and fragments thereof |
| 04/27/2011 | EP2314622A1 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 04/27/2011 | EP2314621A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314620A1 Binding molecules capable of neutralizing rabies virus and uses thereof |
| 04/27/2011 | EP2314619A1 Anti-orthopoxvirus recombinant polyclonal antibody |
| 04/27/2011 | EP2314618A2 Fc variants with altered binding to FcRn |
| 04/27/2011 | EP2314613A2 Genetic products which are differentially expressed in tumours and use thereof |
| 04/27/2011 | EP2314612A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314611A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314610A2 Differential in tumour gene products and use of same |
| 04/27/2011 | EP2314602A1 Improved expression systems with SEC-system secretion |
| 04/27/2011 | EP2314318A1 CD80 antibody for use in combination with chemotherapeutics to treat B cell malignancies |
| 04/27/2011 | EP2314317A2 Anti-glypican 3 antibody |
| 04/27/2011 | EP2314316A1 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2314314A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 04/27/2011 | EP2313504A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 04/27/2011 | EP2313502A1 Methods for systematic control of protein stability |
| 04/27/2011 | EP2313437A1 Cancerous disease modifying antibodies |
| 04/27/2011 | EP2313436A1 Amino acid sequences directed against multitarget scavenger receptors and polypeptides |
| 04/27/2011 | EP2313435A2 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 04/27/2011 | EP2313434A2 Antibodies that neutralize botulinum neurotoxins |
| 04/27/2011 | EP2313433A2 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 04/27/2011 | EP2313364A1 Methods for detecting symmetrical demethylarginine |
| 04/27/2011 | EP2313110A1 Effectors of par-2 activation and their use in the modulation of inflammation |
| 04/27/2011 | EP2313109A2 Il6 immunotherapeutics |
| 04/27/2011 | EP2313095A2 Methods and products for treating proliferative diseases |
| 04/27/2011 | EP1942985B1 Methods for reducing blood pressure |
| 04/27/2011 | EP1863849B1 Rodent pest control |
| 04/27/2011 | EP1732947B1 Growth factor binding constructs materials and methods |
| 04/27/2011 | EP1682665B1 Use of fibroblast growth factor fragments |
| 04/27/2011 | EP1589998B1 IL-27 and IL-2 for use in the treatment of cancer |
| 04/27/2011 | EP1578959B1 Immunizing fish against viral infection |
| 04/27/2011 | EP1539233B1 Super humanized antibodies |
| 04/27/2011 | EP1532174B1 Anti-igf-i receptor antibody |
| 04/27/2011 | EP1432446B1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation |
| 04/27/2011 | EP1419175B1 Replikin peptides and uses thereof |
| 04/27/2011 | EP1368373B1 Environmentally regulated genes, involved in the virulence of streptococcus suis |
| 04/27/2011 | EP1257292B1 Use of il-18 inhibitors |
| 04/27/2011 | CN1845995B Chimeric antigens for breaking host tolerance to foreign antigens |
| 04/27/2011 | CN102037362A Methods and agents for the diagnosis and treatment of hepatocellular carcinoma |
| 04/27/2011 | CN102037136A Products and their use for the diagnosis, prevention, and/or care of human and/or animal pathologies characterised by the anomalous deposition of beta-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 04/27/2011 | CN102037018A Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
| 04/27/2011 | CN102037017A IL-17RA-IL-17RB antagonists and uses thereof |
| 04/27/2011 | CN102037016A Antibodies to granulocyte-macrophage colony-stimulating factor |
| 04/27/2011 | CN102037015A Inhibition of angiogenesis |
| 04/27/2011 | CN102037014A Biomarkers |
| 04/27/2011 | CN102037013A Monoclonal antibodies capable of reacting with a plurality of influenza virus A subtypes |
| 04/27/2011 | CN102037012A Anti-tnfa antibody |
| 04/27/2011 | CN102037011A Methods for treating psoriasis |
| 04/27/2011 | CN102037010A Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
| 04/27/2011 | CN102037007A Selective exosite inhibition of PAPP-A activity against IGFBP-4 |
| 04/27/2011 | CN102036683A Cytotoxic composition |
| 04/27/2011 | CN102031263A Method for preparing human DNA polymerase delta by using bombyx mori bioreactor |
| 04/27/2011 | CN102031245A Monoclonal antibody of avian reticuloendothelial hyperplasia protein gp90 and application thereof |
| 04/27/2011 | CN102030827A Anti-HER2 monoclonal antibody with high affinity |
| 04/27/2011 | CN102030826A High-affinity CD20-resistance monoclonal antibody |
| 04/27/2011 | CN102030825A Troponin I resisting monoclonal antibody and application thereof |
| 04/27/2011 | CN102030824A Monoclonal antibody of hepatitis B virus X protein and use thereof |
| 04/27/2011 | CN102030822A New human cell factor VSTM1-v2 and application thereof |
| 04/27/2011 | CN101555483B Echinococcus granulosus EgFABP-Eg95 polypeptide and preparation and application of recombinant brevibacterium vaccine thereof |
| 04/26/2011 | US7932431 Genetically modified non-human mammals and cells |
| 04/26/2011 | US7932375 Kits for detecting rank nucleic acids |
| 04/26/2011 | US7932372 Antibodies to MAdCAM |
| 04/26/2011 | US7932371 Tick octopamine receptor nucleic acid molecules |
| 04/26/2011 | US7932363 Antibody that binds human eosinophil-derived basic protein |
| 04/26/2011 | US7932362 Antibodies to NRIF3 proteins |
| 04/26/2011 | US7932361 Antibodies to HT5GJ57 |
| 04/26/2011 | US7932360 Recombinant production of mixtures of antibodies |
| 04/26/2011 | US7932359 Anti-caveolin-1 polyclonal antibody, and antigen peptide sequence and method for preparing the same |
| 04/26/2011 | US7932358 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 04/26/2011 | US7932357 for drug screening compunds that affect inappropriate regulation, development, or physiology of antigen presenting cells |
| 04/26/2011 | US7932350 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes |
| 04/26/2011 | US7932229 Peptides for treatment of tumors/cancer |
| 04/26/2011 | US7932066 Unique associated kaposi's sarcoma virus sequences and uses thereof |